GYRE THERAPEUTICS INC

With a trading volume of USD 886.3 k GYRE trades -0.17 percent lower today

Gyre Therapeutics stock dips 0.17%—learn why the $6 bio‑pharma shares, focused on hydronidone for steatohepatitis, are trading below 200‑day SMA.

GYRE THERAPEUTICS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Vanessa Liu

26/10/2026, 15:21

2 minutes to read

Gyre Therapeutics Slides 0.68%: Low Volume, 20% Downward Drift Raises Investor Concerns

Gyre Therapeutics falls 0.68%, trading below its 52‑week low and 200‑day SMA, raising questions on its NASH pipeline’s progress and market confidence.

GYRE THERAPEUTICS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Vanessa Liu

24/10/2026, 03:52

3 minutes to read